Huvudsida

[/news/donald_trump/index.html Donald Trump] sparked backlash from medics around the world after he revealed he is taking an anti-malaria drug to try and protect himself against [/news/coronavirus/index.html coronavirus].
The president, 73, said he began taking hydroxychloroquine - branded as Plaquenil - 'a couple of weeks ago' along because 'good things are being said about it'. 
Trump has often touted it as a treatment for coronavirus, even going so far as to call it a 'cure', after a few early studies - including one in [/news/france/index.html France] - showed positive results in patients.
But the evidence on the anti-malaria drug is mixed, with most of the research onto hydroxychloroquine in the past few weeks showing it has little effect on COVID-19 patients. 
One trial in Brazil was stopped early because so many of the enrolled coronavirus patients given the drug developed irregular heartbeats, a known complication of the drug.
And no evidence currently exists to show the drug can prevent patients being struck down with COVID-19, the disease caused by the coronavirus. 
Here, MailOnline digs into the science behind the drug - also used to treat rheumatoid arthritis and lupus - and reveals what the evidence currently says. 
Hydroxychloroquine is a drug normally used to treat people with lupus or rheumatoid arthritis to try and help control the immune system, which can be overactive in people with those conditions

GLOBAL CLINICAL TRIALS BEGAN IN FEBRUARY 
Scientists and doctors around the world are testing hydroxychloroquine as a potential treatment for people with severe COVID-19.
It may be effective as an anti-viral because it damages viruses in a way which stops them reproducing.

Experts have suggested it makes the internal environment of them too acidic. 
One of the most major signs of its promise is its inclusion in the World Health Organization's global 'Solidarity' trial, which involves medical staff in countries all over the world.
RELATED ARTICLES [# Previous] [# 1] [# Next] [/news/article-8335001/Tube-bosses-tell-commuters-not-use-service-rush-hour.html 'Don't use this station in rush-hour!' Tube bosses tell...] [/news/article-8335549/School-unions-demand-special-bin-maps-paintbrush-cleaning-wardens.html Revealed: Teaching unions demand special 'bin maps',...] [/news/article-8335319/Terrifying-moment-Paralympic-swimmer-manages-race-away-two-SHARKS-Spanish-coast.html Terrifying moment Paralympic swimmer manages to race away...] [/news/article-8335235/Mysterious-COVID-19-cluster-ravages-Chinese-region-100-million-people.html Fears of new coronavirus outbreak in Chinese region of...]



Share this article
Share
106 shares


The WHO said: 'In China and https://dietproperty.pageride.com/diet-to-get-zero-figure-and-desired-body/ France, small studies provided some indications of possible benefit of chloroquine phosphate against pneumonia caused by COVID-19 but need confirmation through randomized trials.'
<div class="art-ins mol-factbox floatRHS news" data-version="2" id="mol-599f78f0-99c2-11ea-abb6-fd27a6f0b539" website do we know about hydroxychloroquine?